FFNT25 ameliorates unilateral ureteral obstruction-induced renal fibrosis

Renal fibrosis is a common pathological feature of chronic kidney disease (CKD) patients who progress to end-stage renal disease (ESRD). With the increasing incidence of CKD, it is of importance to develop effective therapies that blunt development of renal fibrosis. FFNT25 is a newly developed mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wen, Lu, Yue, Lou, Yan, Zhao, Shiyue, Cui, Wenpeng, Wang, Yangwei, Luo, Manyu, Sun, Jing, Miao, Lining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566665/
https://www.ncbi.nlm.nih.gov/pubmed/31140898
http://dx.doi.org/10.1080/0886022X.2019.1612430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566665/
https://www.ncbi.nlm.nih.gov/pubmed/31140898
http://dx.doi.org/10.1080/0886022X.2019.1612430

Ejemplares similares